PMA P030044S005

Device
EGFR pharmDx
Applicant
Agilent Technologies, Inc.
PMA number
P030044
Supplement
S005
Product code
NQF
Decision date
2018-04-10
Classification
Immunohistochemistry Assay, Antibody, Epidermal Growth Factor Receptor
Generic name
Immunohistochemistry assay, antibody, epidermal growth factor receptor
Approval order statement
Modification of equipment and process.

Current openFDA PMA Record#

Device
EGFR pharmDx
Applicant
Agilent Technologies, Inc.
PMA number
P030044
Supplement
S005
Product code
NQF
Generic name
Immunohistochemistry assay, antibody, epidermal growth factor receptor
Decision date
2018-04-10
Decision code
OK30
Date received
2018-03-12
Supplement type
30-Day Notice
Supplement reason
Process Change - Manufacturer/Sterilizer/Packager/Supplier
Approval order statement
Modification of equipment and process.